In contrast, overexpression of PD-L1 indicates that the survival time in patients with breast cancer and certain molecular subtypes of non-small cell lung squamous cell carcinoma would be longer28,29. This evidence concerns the gene CD274 and non-small cell squamous lung carcinoma.